MacroGenics
Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases. Learn more
Launch date
Employees
Market cap
CAD316m
Enterprise valuation
CAD171m (Public information from Sep 2024)
Share price
$3.39 MGNX
Rockville Maryland (HQ)
Authorizing premium user...